2024-520105-39-00招募中1 期
A dosimetry trial of uPAR targeted radioligand therapy in patients with glioblastoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 6
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Hanne Damgaard Jensen
Scientific
Curasight A/S
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A clinical trial of proton radiotherapy with local immunotherapy for recurrent cases with hepatocellular carcinomaHepatocellular CarcinomaJPRN-UMIN000002863Proton Medical Research Center, University of Tsukuba10
已完成
2 期
Radiation protection effect of curcumin in patients with thyroid cancer treated with 131-Idifferentiated thyroid carcinoma(DTC).Malignant neoplasm of thyroid glandIRCT2016020526377N1Vice Chancellor for Research, Shahid Beheshti University of Medical Sciences20
尚未招募
2 期
Application of labeled trastuzumab to diagnose breast cancer in HER2 positive casesMetastatic breast cancer.Malignant neoplasm of breastIRCT20180818040823N2Tehran University of Medical Sciences22
招募中
不适用
Biomarker associated with the radiation therapy of renal cell cancer.C64Malignant neoplasm of kidney, except renal pelvisDRKS00010924niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde10
招募中
1 期
Dose-intensified neoadjuvant radiochemotherapy for operable locally advanced NSCLC Stage III A & Bnonsmall-cell lung cancer (NSCLC)C34Malignant neoplasm of bronchus and lungDRKS00010244niversitätsklinikum Essen35